Stelone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stelone

Quick Facts

Property Description
Active Ingredient Triamcinolone Acetonide
Form Topical (Cream, Ointment, Lotion, Paste)
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Purpose Symptomatic relief of inflammation and itching
Origin Synthetic Steroid

What is Stelone and its Pharmacological Class?

Stelone is a medicinal entity whose active substance is Triamcinolone Acetonide, classifying the medication as a synthetic glucocorticoid, which is a powerful type of corticosteroid. It is primarily a prescription-only (Rx) drug synthesized in a laboratory, establishing it as a highly potent, man-made agent designed to modulate cellular responses. This drug is part of the therapeutic class of anti-inflammatory agents. This pharmacological classification is recognized for its application in controlling localized inflammation. The classification of Triamcinolone Acetonide as a synthetic steroid distinguishes it from hormones naturally produced by the body, offering enhanced anti-inflammatory properties compared to lower-strength glucocorticoids.

Forms, Composition, and Primary Route

The core composition of Stelone is the single-ingredient product Triamcinolone Acetonide combined with a pharmaceutical base tailored for application. Stelone is most commonly presented as a topical preparation, available in various dosage forms including ointment, cream, lotion, and specialized paste formulations. These forms are specifically formulated for a topical route of administration, meaning the medication is intended for localized action directly on the affected skin or mucous membranes. For instance, the paste formulation is a distinctive form often utilized for targeted application on mucous membranes, such as the mouth.

General Purpose: Relief for Inflammatory Conditions

The general purpose of Stelone is to provide effective, symptomatic relief by acting as a powerful anti-inflammatory agent. By modulating localized immune activity and exerting a vasoconstrictive effect, the drug quickly reduces the physical signs of inflammation. The primary benefit it offers is the control and reduction of symptoms associated with various corticosteroid-responsive dermatoses, specifically targeting and alleviating redness, swelling, and persistent pruritus (itching). Triamcinolone Acetonide is recognized for providing this symptomatic relief as part of its therapeutic application.

Regulatory References

  1. U.S. National Library of Medicine

What side effects are possible with Stelone?

Possible Side Effects and Safety Information for Stelone

The safety profile of Stelone, as documented in governmental regulatory sources, centers on a number of adverse reactions across various system-organ classes, with a particular focus on nervous system, psychiatric, and gastrointestinal effects.

Adverse Reactions by System-Organ Class Serious & Clinically Significant Reactions
Nervous System (Very Common: Dyskinesia, Somnolence, Dizziness) Falling asleep without warning during daily activities (sudden sleep onset)
Gastrointestinal (Very Common: Nausea, Diarrhea, Abdominal Pain, Vomiting, Dry Mouth) Drug-induced colitis, Diarrhea (frequently reported)
Psychiatric Depression and suicidality, Hallucinations, Psychotic-like behavior, Impulse control and compulsive behaviors
Vascular Hypotension, Orthostatic Hypotension, Syncope

Serious and Other Noteworthy Safety Information

Abrupt discontinuation of Stelone is associated with a risk of withdrawal-emergent hyperpyrexia and confusion. There is also a documented risk of rhabdomyolysis and an observed increased risk of melanoma in regulatory labels. Certain side effects, such as dyskinesia, may be dose- or exposure-related, with higher incidence noted when combined with other dopaminergic agents.

Safety Restrictions and Population Considerations

The drug is contraindicated in patients with narrow-angle glaucoma. Caution is advised for those with a history of severe cardiovascular disease, myocardial infarction with residual arrhythmias, psychotic disorders, or peptic ulcer disease. Patients must be carefully monitored for mental changes and the development of suicidal tendencies. Because of the risk of somnolence and sudden sleep, patients are restricted from driving or operating machinery if they experience these effects. Dose adjustments and cautious use are specified for patients with mild-to-moderate hepatic impairment or severe renal impairment, including those on dialysis.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profiles for topical Triamcinolone Acetonide (Stelone) define overdose as the result of systemic absorption following prolonged use, application to a large surface area, or the use of occlusive dressings. Overdose is not typically associated with a single application. The manifestations are those of systemic glucocorticosteroid excess.

Documented Overdose Manifestations and Actions

Classification Official Regulatory Statement
Documented Manifestations Manifestations of Cushing's syndrome (Hypercorticism); HPA axis suppression; Hyperglycemia; Glucosuria.
Urgent Help Required When Seek immediate medical attention for suspected accidental ingestion; contact a Poison Control Center or physician immediately for suspected acute systemic toxicity.
Serious Outcomes Reversible HPA axis suppression; secondary adrenocortical insufficiency upon withdrawal.
Special Considerations Pediatric patients show greater susceptibility to systemic toxicity and HPA axis suppression.
Management Approach Symptomatic and supportive treatment; gradual withdrawal of the steroid is necessary if HPA axis suppression is noted. No specific antidote is known.

The official guidance emphasizes that management requires specialized diagnostic evaluation, such as the ACTH stimulation test, to confirm the presence of HPA axis suppression. Recovery is generally prompt upon the gradual discontinuation of the medication. This structure strictly reflects the requirements and warnings present in government-authorized prescribing information.

Therapeutic Uses of Stelone

What Stelone Treats: Main Uses and Benefits

This medication is generally applied in cases where additional symptomatic support is needed and is relevant in contexts involving inflammatory or irritative processes. Stelone is commonly used across conditions presenting with acute episodes, generally supporting relief for conditions such as eczema, atopic dermatitis, psoriasis, and contact dermatitis. It is applied in clinical settings that involve acute or unstable symptom patterns.

The medication is commonly used to help with symptoms related to physical discomfort, particularly intense itching (pruritus), visible redness, and localized swelling. This supportive relief helps address symptom clusters that may become intense or disruptive over time, and may assist with maintaining a sense of stability when symptoms are more noticeable. This supportive relief supports patients during episodes of heightened discomfort.

It is also commonly used in situations involving certain distressing symptoms where focused relief is relevant, such as in addressing oral inflammatory lesions or supporting relief from persistent plaques using a specialized paste formulation.

“This medication is commonly used to help with symptoms related to physical discomfort.”


Quick Fact: Relief for Inflammatory Symptoms
Primary Focus: Supportive relief for symptoms of inflammatory skin and mucosal conditions.
Symptom Clusters: Itching (pruritus), redness, and localized swelling.
Common Context: Symptomatic relief during acute episodes of chronic conditions.

Regulatory References

  1. NIH MedlinePlus Drug Information on Triamcinolone Topical

Eligibility and Restrictions for Use

Eligibility Scope: Who Can and Cannot Use Stelara (ustekinumab) — Official Regulatory Information

Populations for whom use is contraindicated: Stelara must not be used by individuals with a known clinically significant hypersensitivity to ustekinumab or any component of the formulation. Treatment initiation is also absolutely contraindicated in patients with a clinically important active infection, including confirmed active tuberculosis (TB) infection.

Age-Related Eligibility Rules:

Population Eligibility Status Conditions for Use
Adults Eligible For all approved indications.
Pediatric Patients (6 years and older) Eligible For Plaque Psoriasis and Psoriatic Arthritis.
Pediatric Patients (Under 6 years) Use not established Safety and effectiveness are not established for any indication.

Use Requiring Restriction or Special Consideration:

Patients must be evaluated for TB infection prior to initiating treatment; if latent TB is detected, it must be treated before Stelara is administered. Administration of live viral or live bacterial vaccines is generally not recommended during therapy. Caution is advised for patients with a chronic or recurrent infection or those with a history of malignancy, as safety in these groups has not been fully evaluated in clinical studies. For pregnancy, ustekinumab is known to cross the placental barrier, and the medicine is excreted into human milk during lactation.

What should I know about interactions with other medicines?

The official regulatory documents for Stelone (Triamcinolone Acetonide Topical) confirm that the potential for systemic drug interactions exists primarily when the medication is applied over large surface areas, used for prolonged periods, or utilized with occlusive dressings, allowing for increased absorption into the bloodstream.

Pharmacokinetic and Exposure Effects

Pharmacokinetic interactions center on the metabolism of the active ingredient. Co-administration with known hepatic enzyme inducers, such as Carbamazepine, Phenytoin, and Rifampicin, may increase the rate at which Triamcinolone Acetonide is broken down. This interaction can lead to reduced systemic exposure to the corticosteroid component. Conversely, certain agents like oral contraceptives have been associated with a prolongation of the half-life of triamcinolone acetonide.

Pharmacodynamic and Additive Effects

A key pharmacodynamic interaction is documented with potassium-depleting diuretics. The concomitant use of these medicines may increase the risk of hypokalaemia (low serum potassium) due to an additive effect on the body's potassium balance. Caution is also advised when Stelone is used with other corticosteroid-containing products to avoid the potential for additive systemic effects.

Restrictions and Contraindications

The official labeling does not contain any mandatory timing rules for separating the administration of other medicines from Stelone. Furthermore, no specific drug-drug combinations are officially listed as being contraindicated based purely on an interaction mechanism. The regulatory information also confirms no documented interactions with food, alcohol, or herbal products for the topical formulation.

Mechanism of Action

How Stelone Works: Mechanism of Action

Triamcinolone Acetonide exerts its effects by engaging cellular machinery to fundamentally modulate the localized inflammatory cascade. Its primary action is concentrated in three major mechanistic domains that collectively modify inflammatory signaling.

Intracellular Receptor Activation and Genomic Modulation

Action begins with binding and activation of the cytosolic Glucocorticoid Receptor ( GR). This triggers the genomic pathway, where the drug-receptor complex modulates gene expression to simultaneously reduce the synthesis of pro-inflammatory proteins (like cytokines) and increase the production of anti-inflammatory proteins (like Lipocortin-1), thereby modulating the inflammatory cellular response.

Cascade Blockade and Mediator Suppression

This domain blocks the chemical processes that produce inflammatory mediators. By inducing Lipocortin-1, Stelone indirectly blocks the key enzyme Phospholipase A2 ( PLA2), preventing the release of arachidonic acid and thus reducing the entire downstream cascade responsible for synthesizing inflammatory compounds like prostaglandins and leukotrienes.

Vascular and Immune Cell Regulation

At the tissue level, the overall reduction of mediators leads to localized vasoconstriction (blood vessel narrowing) and a reduced ability for immune cells, such as leukocytes, to migrate into the affected tissue. This regulation of local blood flow and cell trafficking results in limited fluid exudation and cell accumulation at the site.

Dosage and Administration Information

How to Use Stelone (Triamcinolone Acetonide Topical) – Official Administration Guidelines

This information details the administration protocol for Stelone.

Administration Scope and Dosing

Administration Component Official Instruction
Approved Routes Topical (Dermatologic) Use for creams, ointments, and lotions; Oral (Mouth) Use for dental paste. Not for ophthalmic use.
Dosing/Amount Apply a thin film to the affected area. For dental paste, press a small dab (approx. 1/4 inch) onto the lesion; do not rub in the paste.
Standard Frequency Typically two to four times daily, depending on the specific dosage form and strength. Dental paste is often applied at bedtime and/or after meals.

Procedural and Population-Specific Rules

Special Procedural Conditions:

The treated skin area must not be bandaged or covered with an occlusive dressing unless explicitly directed by a healthcare provider. This restriction is a mandatory element of the application procedure.

Age-Group Administration:

For pediatric patients, administration should be limited to the least amount of medication compatible with an effective outcome. If using the product in the diaper area, it is necessary to avoid tight-fitting diapers or plastic pants, as these can create an occlusive environment.

Course Duration:

Treatment should be discontinued when control is achieved or if improvement is not observed promptly. The dental paste is designed to show improvement within one week.


Note: This section strictly outlines the official usage procedures and must not be used as a substitute for medical advice.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Stelone

Evidence for Use in Corticosteroid-Responsive Skin Conditions

The research landscape explores the use of topical Triamcinolone Acetonide (Stelone) in various inflammatory skin issues, which are conditions characterized by fluctuating or episodic manifestations. The primary data supporting this use comes from short-term Randomized Controlled Trials (RCTs). These studies monitored patient populations that included adults and children with varying symptom burdens.

The research was specifically focused on outcomes linked to inflammatory or irritative states. Studies measured changes in specific signs, such as redness (erythema), swelling (induration), and pruritus (itching), using standardized clinical scores. The findings describe patterns observed in the studies related to how the inflammatory signs were measured during the short follow-up periods. The findings were mixed across some comparative studies, which reflects differences in the specific formulations or comparators utilized.

Evidence for Use in Chronic Conditions: Eczema and Psoriasis

The research structure was studied for use in chronic conditions, such as Atopic Dermatitis (Eczema) and Psoriasis (Plaque Psoriasis). For eczema, studies included RCTs, including those designed to monitor proactive use protocols. Research highlights changes measured during the study period in established severity scores (like EASI) and patient-reported outcomes describing perceived discomfort, specifically itching intensity. For psoriasis, research describes patterns related to the measured change in plaque characteristics.

Data for the long-term effects are not fully established. For psoriasis, the research mainly applies to mild-to-moderate plaques, and subgroup findings are uncertain for treating very thick skin areas. For eczema, research exploring maintenance outcomes has typically only been monitored for intermediate terms (up to 4–5 months).

Evidence in Special Populations, Including Children

Stelone was studied for use in certain special populations, including pediatric patients (children and infants) with conditions like atopic dermatitis. Research describes the outcomes related to physical discomfort that were measured in these younger populations. However, the scientific literature has noted that data for certain groups remain insufficient. Due to the recognized potential for higher systemic absorption in children compared to adults, evidence is limited regarding the long-term safety profile of extended use, and specific subgroup findings are uncertain for certain dosage strengths.

Key Studies & References TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.025%, 0.1% - DailyMed (FDA Drug Label)

Frequently Asked Questions (FAQ)

Common questions about Stelone (FAQ)

Q: Does Stelone cause weight gain, and if so, how common is it?

A: Weight gain is not typically listed as a primary side effect of the topical form of Stelone. However, if the medication is absorbed into the bloodstream (due to use over large areas, prolonged periods, or with occlusive dressings), it can lead to signs of increased steroid exposure, which include weight gain or changes in body fat distribution. Any persistent or unusual weight gain should be discussed with a healthcare professional.


Q: How long does it typically take for a person to start feeling the effects of Stelone?

A: Topical corticosteroids are generally intended to provide relief from inflammation and itching. While official product information does not specify an exact time-to-onset (like hours or days) for initial relief, the formulation designed for use in the mouth (dental paste) is specifically indicated to show improvement within one week. If symptom reduction is not prompt, this should be discussed during a follow-up with a healthcare provider.


Q: Will Stelone interact negatively with birth control pills?

A: Regulatory information indicates that oral contraceptives have been associated with a prolongation of the half-life of triamcinolone acetonide (the active ingredient in Stelone). This means that the contraceptive could potentially increase the time the corticosteroid stays in your system, which might lead to increased effects of the medication.


Q: Are headaches a common side effect when first starting Stelone?

A: Headaches have been listed as a potential systemic side effect, especially when the active ingredient is absorbed in higher amounts into the body. Systemic side effects are less common with proper topical use. New or severe headaches experienced after starting treatment should be reported to a healthcare professional.


Q: Can Stelone affect your sleep patterns, making it harder to fall or stay asleep?

A: Sleep disturbances are a reported adverse reaction. Official labeling has noted both insomnia (sleeplessness) and, conversely, somnolence (drowsiness) as potential side effects. Any changes in sleep patterns should be discussed with a healthcare provider.


Q: Will Stelone interact negatively with common supplements like multivitamins or fish oil?

A: Official labeling for the topical formulation confirms there are no documented interactions with general food, alcohol, or herbal products. No specific warnings or interactions are documented for general supplements like multivitamins or fish oil. However, it is generally recommended to inform a healthcare provider about all supplements being taken.


Q: Will Stelone show up on a standard drug test?

A: Stelone is classified as a synthetic glucocorticoid, a type of corticosteroid. While the regulatory documents do not comment on its detection in commercial drug tests, corticosteroids are sometimes included in anti-doping or other specialized drug screens. This classification is relevant when considering specialized drug testing.


Q: Is Stelone a controlled substance or habit-forming?

A: The active ingredient in Stelone, triamcinolone acetonide, is not classified as a federally controlled substance and is not considered habit-forming. However, abrupt discontinuation is associated with a risk of a withdrawal syndrome, including fever and confusion. Any decision to stop the medication should be made in consultation with a healthcare professional.


Q: Can you drink alcohol while taking Stelone, or is that interaction risky?

A: Official product information for the topical formulation confirms that there are no documented interactions with alcohol. While the medication itself does not directly interact with alcohol, consumption of alcohol may worsen certain underlying skin conditions that Stelone is prescribed to treat. Alcohol consumption should be discussed with a healthcare provider.


Q: Is it normal to feel more tired than usual in the first week of taking Stelone?

A: Unusual tiredness or somnolence (drowsiness) are among the systemic adverse reactions that have been reported with the use of this medication. This feeling may be related to the body's initial adjustment to the corticosteroid. Persistent or worsening systemic symptoms should be reported to a healthcare provider.


Q: Has Stelone been studied for use in people with kidney or liver issues?

A: Topical corticosteroids are metabolized primarily in the liver and excreted by the kidneys. Official information specifies that cautious use and dose adjustments may be necessary for patients who have mild-to-moderate hepatic (liver) impairment or severe renal (kidney) impairment. These precautions relate to how the drug is processed and eliminated by the body.


Q: What kind of studies support the use of Stelone for its primary indications?

A: The research supporting the official uses of the drug is based primarily on short-term Randomized Controlled Trials (RCTs). These studies were designed to monitor outcomes linked to inflammatory and irritating skin conditions, specifically measuring changes in signs like redness, swelling, and itching.


Q: Do people with asthma or allergies need to be more careful when taking Stelone?

A: The drug is contraindicated (must not be used) in individuals who have a known, clinically significant hypersensitivity (a severe allergic reaction) to triamcinolone acetonide or any of the inactive ingredients in the formulation. Asthma and general allergies are not explicitly listed as contraindications, but a history of severe allergic reactions is important information to discuss with the prescriber.


Q: Is Stelone effective for all patients, or is there a high rate of non-responders?

A: Research has noted that findings were mixed across some comparative studies, indicating that patient response may vary. Official guidelines state that treatment should be stopped if improvement is not observed promptly. The lack of prompt effectiveness is an official guideline for determining treatment continuation.


Q: Can Stelone cause changes in appetite?

A: Changes in appetite have been reported. Increased appetite is a known systemic side effect associated with corticosteroids. This is typically a concern when the drug is absorbed into the bloodstream, such as when it is used over large areas of the body or under occlusive dressings for extended periods.


Q: What does the latest research suggest about the long-term safety profile of Stelone?

A: Regulatory documents explicitly state that the data for the long-term effects of this medication are not fully established. Evidence is considered limited regarding the long-term safety profile of extended use, particularly for children. Continuous treatment requires monitoring by a healthcare professional.


Q: Is it common to feel jittery or anxious after starting Stelone?

A: Official labeling reports that anxiety and irritability have been noted as psychiatric adverse reactions. These effects are often associated with the systemic absorption of corticosteroids. Any mental or behavioral changes should be discussed with a healthcare professional.


Q: What is the typical time frame for re-evaluating the effectiveness of Stelone?

A: The duration of treatment is determined individually by the healthcare provider. While the dental paste is expected to show improvement within one week, the general guidance is that treatment should be stopped if improvement is not observed promptly. Regular follow-up allows your provider to assess effectiveness.


Q: Can Stelone cause mood swings or changes in temperament?

A: New or worsening mental health effects, including mood swings, euphoria, and personality changes, have been reported in official documents as side effects associated with systemic corticosteroid exposure. Any changes in temperament or mental state should be discussed with a healthcare professional.


Q: Can Stelone affect your ability to drive or operate machinery?

A: Official product information states that patients are restricted from driving or operating machinery if they experience certain side effects, specifically somnolence (drowsiness) or sudden sleep. This warning is based on the potential for these adverse reactions to impair judgment.


Q: Why might a doctor increase or decrease the Stelone dose during treatment?

A: Dosage may be adjusted (by reducing frequency or potency) if the patient shows signs of HPA axis suppression. This is a medical condition where the body is absorbing too much of the steroid. Adjustments are made by the doctor to balance the therapeutic effectiveness of the drug against its potential for systemic absorption.


Q: Is a generic version of Stelone available?

A: Yes, the active ingredient in Stelone is Triamcinolone Acetonide. This compound is a widely available generic glucocorticoid, and there are many FDA-approved, equivalent generic products available on the market.


Q: Will Stelone make other conditions I have better or worse?

A: The presence of certain medical problems may affect the use of this medicine. Conditions like Cushing's syndrome, diabetes, or hyperglycemia (high blood sugar) may be made worse by the systemic absorption of the drug. Caution is advised for patients with these pre-existing conditions.

How should Stelone be stored and disposed of?

Storage and Disposal Requirements

Stelone (Triamcinolone Acetonide Topical) must be stored according to regulatory specifications to maintain its stability. The medication requires storage at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). It is mandatory to keep the product from freezing and to protect it from excess heat, moisture, and direct light.

The medication must remain in its original container and be kept tightly closed when not in use.

Child-Safety and Disposal

For child safety, the product must be stored out of the sight and reach of children, preferably in a secure, locked location. Disposal of unused or expired medicine should follow official guidelines: mix the product with an undesirable substance (such as dirt or kitty litter), seal it in a plastic bag, and discard it in the household trash. Aerosol forms have the specific warning not to be punctured or incinerated.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stelone found in:

A-Z Index: